Press release
Stroke Post Processing Software Market Hit US$ 417.53 Million by 2032 | Key Players: Siemens Healthineers; General Electric Company; Brainomix Limited; iSchemaView; Viz.ai Inc
Browse Full Report: https://www.factmr.com/report/stroke-post-processing-software-market
Why Is the Market Expanding?
The global stroke burden, with a 70% increase in incident cases from 1990 to 2019, drives demand for advanced diagnostic tools, as strokes cost over US$ 721 billion annually (0.66% of global GDP). AI and machine learning integration, adopted by 40% of stroke diagnostics in 2024, enhances detection accuracy by 20%, particularly for ischemic strokes, which account for 87% of cases. The rise in healthcare investments, with U.S. stroke-related costs reaching US$ 46 billion between 2014 and 2015, supports software deployment in hospitals and clinics, capturing 76% of market revenue. Innovations like iSchemaView's RAPID ANGIO, launched in 2019, improve acute stroke diagnosis by 15%. Regulatory support, such as FDA's 2024 AI diagnostic approvals, boosts adoption, while high costs (US$ 10,000-50,000 per license) are mitigated by cloud-based solutions, reducing expenses by 10%.
What Are the Key Market Projections?
The market is set to create an absolute dollar opportunity of US$ 239.53 million by 2032, growing from US$ 178 million in 2022 to US$ 417.53 million at an 8.9% CAGR. The MRI-based software segment, holding a 60% share in 2022, is projected to grow at a 9.2% CAGR, generating US$ 150 million in opportunities due to its precision in detecting ischemic strokes. North America, with a 47% share in 2022, leads with an 8.5% CAGR, driven by U.S. healthcare spending and collaborations like GE's 2021 partnership with Circle Neurovascular Imaging. Asia-Pacific, growing at a 9.5% CAGR, benefits from China's US$ 30 billion healthcare tech investments. Historical growth from 2015 to 2021 averaged a 9.2% CAGR, with acceleration expected. Short-term growth (2022-2026) focuses on hospitals, while long-term trends (2027-2032) emphasize mobile and tablet-based solutions, growing at an 8.7% CAGR.
How Can Stakeholders Capitalize on Opportunities?
Stakeholders in healthcare and technology sectors can leverage opportunities by investing in AI-driven software, like Brainomix's 2024 e-Stroke suite, enhancing diagnostic speed by 25%. Partnerships, such as Siemens Healthineers' 2020 collaboration with Stroke International Services for 3T MRI systems, expand market reach in Asia-Pacific, projected to account for 35% of demand by 2030. Focusing on cloud-based platforms, contributing 20% of revenue in 2022, ensures scalability and affordability. Compliance with FDA and EU IVDR standards boosts market trust, while targeting high-growth markets like India, with a 10% CAGR, unlocks potential. Developing mobile-based solutions, like Viz.ai's 2024 stroke detection app, addresses rural healthcare gaps, increasing adoption by 15%.
Want a Sample Before Buying? Download Free Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=7133
What Does the Report Cover?
Fact.MR's report analyzes the Stroke Post Processing Software Market across 30+ countries, covering segments by installation (desktop-based, mobile phones & tablet-based), modality (CT scan-based, MRI-based), software type (ischemic stroke, hemorrhagic stroke), end-use (hospitals & clinics, diagnostic centers, others), and region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa). It highlights trends like AI integration, cloud-based platforms, and point-of-care diagnostics. Combining primary research from industry experts and secondary data, the report provides actionable insights into market dynamics, competitive strategies, and growth opportunities through 2032.
Who Are the Market Leaders?
Key players include Siemens Healthineers, General Electric Company, Brainomix Limited, iSchemaView, and Viz.ai Inc. Siemens' 2020 MAGNETOM Lumina 3T MRI integration strengthened its diagnostic portfolio, while Brainomix's 2024 e-Stroke suite gained traction in Europe. These companies, holding over 50% of the market, drive innovation through R&D and partnerships, such as GE's 2021 FastStroke platform with Circle Neurovascular Imaging. Regional players like RapidAI focus on cost-effective solutions for Asia-Pacific, enhancing competitiveness. Strategic acquisitions, like iSchemaView's 2023 expansion of RAPID software, bolster market presence.
What Challenges and Solutions Exist?
High software costs (US$ 10,000-50,000 per license) and complex regulatory approvals, delaying launches by 12-18 months, pose challenges. Limited skilled radiologists, affecting 15% of facilities, and data privacy concerns, impacting 10% of deployments, hinder growth. Solutions include cloud-based platforms, reducing costs by 10%, and AI automation, improving diagnostic efficiency by 20%, as seen in Viz.ai's 2024 updates. Localized development in Asia-Pacific, adopted by 20% of providers, mitigates supply risks. Training programs, implemented by 15% of U.S. hospitals in 2024, address skill gaps. Compliance with HIPAA and GDPR standards ensures data security and market resilience.
What Are the Recent Developments?
In 2024, global stroke cases rose by 5%, boosting software demand by 10%, particularly for ischemic stroke diagnostics. North America's 47% share reflects U.S. advancements, with 129,624 genetic and imaging tests available in 2022.
Brainomix's 2024 e-Stroke suite, integrating AI for faster lesion detection, improved outcomes by 15%. Siemens Healthineers' 2024 syngo DynaCT Multiphase upgrade enhanced angiography precision by 12%. Asia-Pacific's growth, driven by China's 20% increase in healthcare tech funding, supports mobile-based software adoption, rising 18%. Regulatory advancements, like the EU's 2024 IVDR, increased compliant software deployment by 10%. Viz.ai's 2024 mobile app launch addressed rural stroke care, reducing diagnosis time by 20%.
Check out More Related Studies Published by Fact.MR:
Clientless Remote Support Software Market: https://www.factmr.com/report/345/clientless-remote-support-software-market
Diabetes Management Software Market: https://www.factmr.com/report/431/diabetes-management-software-market
Bone Marrow Processing System Market: https://www.factmr.com/report/1297/bone-marrow-processing-systems-market
Atrial Fibrillation Stroke Treatment Market: https://www.factmr.com/report/1716/atrial-fibrillation-stroke-treatment-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stroke Post Processing Software Market Hit US$ 417.53 Million by 2032 | Key Players: Siemens Healthineers; General Electric Company; Brainomix Limited; iSchemaView; Viz.ai Inc here
News-ID: 4126855 • Views: …
More Releases from Fact.MR
Trauma Devices Market is Estimated to Reach USD 29.1 Billion by 2035 | DePuy Syn …
Fact.MR today released its latest report on the Trauma Devices Market, providing comprehensive insights into the global market's robust growth driven by rising traumatic injuries, advancements in medical technologies, and increasing global awareness of trauma care. Valued at USD 12.9 billion in 2025, the market is projected to expand at a compound annual growth rate (CAGR) of 8.7%, reaching USD 29.1 billion by 2035.
For More Insights into the Market,…
Microbiome Therapeutics Market is Projected to Reach USD 3,121.8 Million by 2035 …
The global microbiome therapeutics market is valued at USD 823.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 14.2%, reaching USD 3,121.8 million by 2035. This robust expansion is driven by the increasing recognition of the human microbiome's role in managing chronic diseases, combined with rising investments in precision medicine and biotechnology innovation. As research uncovers the microbiome's influence on health conditions…
Insulin Patch Pumps Market is Anticipated to Reach USD 4.29 Billion by 2035
The global insulin patch pumps market is poised for substantial growth, with its valuation expected to rise from USD 1.42 billion in 2025 to USD 4.29 billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 11.7%. This expansion is primarily driven by the escalating prevalence of diabetes worldwide and the increasing demand for convenient, discreet insulin delivery devices. As patients seek wearable insulin management systems that offer…
Wearable Payment Devices Market is Expanding USD 133.09 Billion by 2034 | Fact.M …
The global wearable payment devices market is valued at USD 33.47 billion in 2024 and is projected to expand to USD 133.09 billion by 2034, growing at a compound annual growth rate (CAGR) of 14.8%. This impressive growth is driven by the increasing adoption of contactless payment technologies, advancements in wearable devices, and rising consumer preference for convenient, secure transaction methods.
For More Insights into the Market, Request a Sample…
More Releases for Stroke
Key Trends Reshaping the Acute Ischemic Stroke Diagnosis Market: Companies Revol …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Acute Ischemic Stroke Diagnosis Market Size Growth Forecast: What to Expect by 2025?
The market for diagnosing acute ischemic stroke has seen robust expansion in the last few years. The market size is forecasted to increase from $2.32 billion in 2024 to $2.48 billion in 2025, with a compound…
Stroke Diagnostics Market to Witness Robust Growth Amid Rising Stroke Incidence …
Market Overview
The stroke diagnostics market is estimated to be valued at USD 3.34 Bn in 2025 and is expected to reach USD 5.83 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.
Coherent Market Insights has released a comprehensive new report offering an in-depth analysis of the Stroke Diagnostics Market from 2025 to 2032. This study provides reliable global and regional projections, helping…
Key Trends Shaping the Future Acute Ischemic Stroke Diagnosis Market From 2025-2 …
Which drivers are expected to have the greatest impact on the over the acute ischemic stroke diagnosis market's growth?
The acute ischemic stroke diagnosis market is predicted to expand due to the growing number of acute ischemic stroke incidents. Acute ischemic stroke is a serious health emergency caused by inadequate blood flow to the brain, leading to brain cell damage. Prompt detection of acute ischemic stroke can assist in treatment, minimize…
Ischemic Stroke Aspiration Systems Market: Advancing Stroke Treatment with Innov …
Introduction
The ischemic stroke aspiration systems market is undergoing remarkable growth, driven by technological innovations and increasing awareness of advanced treatment options for stroke management. Ischemic stroke, the most common type of stroke, occurs when blood flow to a part of the brain is blocked, often due to a blood clot. This obstruction can lead to significant brain damage, disability, and even death if not treated swiftly. Aspiration systems, a vital…
Stroke Management Market Size To Reach USD 36.75 Billion, Globally, By 2023 | Di …
Asia-Pacific is expected to grow with the highest market share during the analysis period and would provide high opportunities for the market players.
The global stroke management market was valued at $22,581 million in 2016, and is estimated to reach $36,756 million by 2023, growing at a CAGR of 7.1% from 2017 to 2023. The diagnostics segment held more than five-seventh share of the total market in 2016.
Download Free Report Sample…
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to…
